Allan M. Fox - 02 Jun 2023 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
02 Jun 2023
Net transactions value
$0
Form type
4
Filing time
06 Jun 2023, 17:14:19 UTC
Previous filing
07 Jun 2022
Next filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Award $0 +3,486 +116% $0.000000 6,496 02 Jun 2023 Direct F1
holding RGNX Common Stock 722,485 02 Jun 2023 By AMF Family Gift Trust LLC F2
holding RGNX Common Stock 315,000 02 Jun 2023 By AMF Gift Trust LLC F2
holding RGNX Common Stock 315,000 02 Jun 2023 By HBF Gift Trust LLC F2
holding RGNX Common Stock 1,529,981 02 Jun 2023 By Quaker Gray LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Options (Right to Buy) Award $0 +17,892 $0.000000 17,892 02 Jun 2023 Common Stock 17,892 $19.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.
F2 The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.